explore -WSS

explore

author：comprehensive 2025-10-01 18:34:53 - browse：32477

Since the early days of the pandemic, long Covid has haunted us: Even a mild acute infection might leave you with life-altering consequences. And for many, that has, sadly, turned out to be the case. While research suggests long Covid rates are falling, it still affects millions. In June 2023, 6% of Americans reported experiencing long Covid.

But what if long Covid isn’t the right way to think about what they are going through?

On this episode of the First Opinion Podcast, I spoke with Steven Phillips and Michelle A. Williams, authors of a recent First Opinion essay titled, “Long Covid is a new name for an old syndrome.” Steven is a Global Virus Network board member and vice president for science and strategy at the COVID Collaborative; Michelle is the former dean and current Joan and Julius Jacobson professor of epidemiology and public health at the Harvard T.H. Chan School of Public Health.

“Michelle and I have come up with basically a new paradigm that says long Covid is really an old disease, and the more you do deep dives into the history of chronic fatigue syndrome and post-infectious fatigue syndromes, the more you realize that not only are there similarities, but the level of congruence between the two is strikingly high,” Steven said.

The purpose of this new paradigm is to “break the logjam” of the current long Covid discourse and “to try to provide a framework whereby people would think about long Covid in a different way in a way that would be more productive,” Michelle told me.

We discussed the history of post-infectious disease syndrome, what rethinking long Covid might mean for research, and the ways the health care system fails chronically ill patients.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： Sports medicine is finally prioritizing gender equality
Next article： FDA approves Moderna’s RSV vaccine, its second licensed product

WSS

ADCs take center stage as promising cancer treatments

Results on Novartis prostate cancer therapy could expand its use

Anthony Fauci pushes back on GOP claims during Covid hearing

FDA approves Moderna’s RSV vaccine, its second licensed product

Anthony Fauci pushes back on GOP claims during Covid hearing

The most pressing bird flu mysteries scientists want answered

focus

explore

entertainment

In Memoriam: Notable people who died in 2023

How CO2 helps viruses stay alive longer in the air

Medicare details structure of new drug price negotiation program

STAT Readout Newsletter: Biotech news today

BioMarin wins approval for gene therapy to treat hemophilia A

An outdated Medicare rule harms dementia patients with anxiety

After affirmative action ruling, medical educators look to 'holistic review'

STAT Summit: Ending the crisis of Black deaths in the U.S.

George Santos makes 1st court appearance after pleading not guilty to 13 counts

UnitedHealth CEO's Medicaid comments send insurer stocks diving

Wikipedia

Data don't support strong claims for Covid

STAT Readout: Friday, Oct. 20 biotech updates

STAT Summit: How researchers deal with rejection

Why a market frenzy over new weight loss drugs defies logic

Illumina board agrees to spin off Grail, as divestment plans proceed

Is there really a nursing shortage in the U.S.?

focus

focus

hotspot

hotspot